Prognostic Factors for Adverse Outcomes in COVID-19 Infection.
Zarir Udwadia, Awatansh Kumar Rajkumar Tripathi, Viral Nanda, Shashank Joshi
2020PubMed21 citations
Abstract
Whilst COVID-19 infection generally run a mild course in up to 80% of those affected, a number of pre-existing co-morbidities determine the severity of infection and the outcome in an individual patient. The most important of these co-morbidities that have consistently emerged in studies from across the globe, are the patients age and sex. Other important co-morbidities that adversely affect outcomes include pre-existing diabetes, obesity, hypertension, chronic lung disease and malignancy. This comprehensive review discusses the impact of these co-morbidities and the role of laboratory predictors of poor patient outcomes.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)ComorbidityObesityDiabetes mellitusMalignancyIntensive care medicineDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineInfectious disease (medical specialty)EndocrinologyCOVID-19 Clinical Research StudiesCOVID-19 Impact on ReproductionCOVID-19 and healthcare impacts